Ridgeback Biotherapeutics Archives -

The US federal government has ordered another 1.4 million doses of Merck & Co and Ridgeback Biotherapeutics’ oral

US buys another $1 billion-worth of Merck’s COVID capsule

https://pharmaphorum.com/news/us-buys-another-1-billion-worth-of-mercks-covid-capsule/

As expected, Merck & Co has moved ahead swiftly with an emergency use application for its oral antiviral

Merck files pill for milder COVID, as AZ showcases its antibody data

https://pharmaphorum.com/news/merck-files-pill-for-milder-covid-as-az-showcases-its-antibody-data/

The AGILE programme, which is researching a second wave of COVID-19 therapies in the UK, has begun testing its first potential

UK trial begins testing second-wave COVID-19 drug from US biotech Ridgeback

https://pharmaphorum.com/news/uk-trial-begins-testing-second-wave-covid-19-drug-from-us-biotech-ridgeback/

Ridgeback Biotherapeutics